Cargando…

Resistance to Second-Line Antituberculosis Drugs and Delay in Drug Susceptibility Testing among Multidrug-Resistant Tuberculosis Patients in Shanghai

Introduction. Second-line antituberculosis drugs (SLDs) are used for treating multidrug-resistant tuberculosis (MDR-TB). Prolonged delays before confirming MDR-TB with drug susceptibility testing (DST) could result in transmission of drug-resistant strains and inappropriate use of SLDs, thereby incr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yong, Yuan, Zhengan, Shen, Xin, Wu, Jie, Wu, Zheyuan, Xu, Biao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019859/ https://www.ncbi.nlm.nih.gov/pubmed/27652260 http://dx.doi.org/10.1155/2016/2628913

Ejemplares similares

Mycobacterium tuberculosis resistance to antituberculosis drugs in Mozambique,
por: Pires, Germano Manuel, et al.
Publicado: (2014)

Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil,
por: Micheletti, Vania Celina Dezoti, et al.
Publicado: (2014)

Drug Resistance Patterns of Multidrug- and Extensively Drug-Resistant Tuberculosis in Korea: Amplification of Resistance to Oral Second-line Drugs
por: Kim, Chang-Ki, et al.
Publicado: (2017)

Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania
por: Mpagama, Stellah G, et al.
Publicado: (2013)

Acquired Resistance to Antituberculosis Drugs
por: Aung, Htin Lin, et al.
Publicado: (2018)

Epidemiology of tuberculosis and susceptibility to antituberculosis drugs in Reunion Island
por: Loukman, Moreea, et al.
Publicado: (2023)

Pattern of drug resistance of Mycobacterium tuberculosis clinical isolates to first-line antituberculosis drugs in pulmonary cases
por: Kalo, Deepika, et al.
Publicado: (2015)

Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study
por: Davies Forsman, Lina, et al.
Publicado: (2018)

Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China
por: Zheng, Xubin, et al.
Publicado: (2022)

Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis
por: van der Laan, Louvina E., et al.
Publicado: (2021)

Incidence and predictors of acquired resistance to second-line antituberculosis drugs during the course of multi-drug resistant tuberculosis treatment: protocol for a systematic review and meta-analysis
por: Alemu, Ayinalem, et al.
Publicado: (2023)

Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China
por: Wu, Zheyuan, et al.
Publicado: (2020)

Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011
por: Nguyen, Hoa Binh, et al.
Publicado: (2016)

Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait
por: Al-Mutairi, Noura M., et al.
Publicado: (2021)

Prevalence and Molecular Characterization of Second-Line Drugs Resistance among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Southwest of China
por: Hu, Y., et al.
Publicado: (2017)

Economic evaluation of a shortened standardised treatment regimen of antituberculosis drugs for patients with multidrug-resistant tuberculosis (STREAM): study protocol
por: Gama, Elvis, et al.
Publicado: (2016)

Interruptions in Supplies of Second-Line Antituberculosis Drugs — United States, 2005–2012
por: Seaworth, Barbara J., et al.
Publicado: (2013)

Efficacy and effect of free treatment on multidrug-resistant tuberculosis
por: ZHANG, QING, et al.
Publicado: (2016)

Drug-Susceptible and Multidrug-Resistant Mycobacterium tuberculosis in a Single Patient
por: Baffoe-Bonnie, Anthony, et al.
Publicado: (2019)

Clinical Efficacy of a Combination of Thymopentin and Antituberculosis Drugs in Treating Drug-Resistant Pulmonary Tuberculosis: Meta Analysis
por: Han, Yi-Ran, et al.
Publicado: (2022)

Pharmacokinetics of Antituberculosis Drugs in Plasma and Cerebrospinal Fluid in a Patient with Pre-Extensive Drug Resistant Tuberculosis Meningitis
por: Liang, Zhilin, et al.
Publicado: (2023)

Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana
por: Mogashoa, Tuelo, et al.
Publicado: (2019)

Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco
por: Oudghiri, Amal, et al.
Publicado: (2018)

Impact of universal drug susceptibility testing and effective management of multidrug-resistant tuberculosis in Taiwan
por: Lee, Pin-Hui, et al.
Publicado: (2019)

Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis
por: Pérez-Lago, Laura, et al.
Publicado: (2015)

Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis
por: Cho, Hyun Jin, et al.
Publicado: (2020)

Adverse Reactions to Antituberculosis Drugs in Iranian Tuberculosis Patients
por: Farazi, Aliasghar, et al.
Publicado: (2014)

Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis
por: Wu, Chunli, et al.
Publicado: (2023)

Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates
por: Kaniga, Koné, et al.
Publicado: (2022)

Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case
por: Osei-Wusu, Stephen, et al.
Publicado: (2018)

Effect of mobile health reminders on tuberculosis treatment outcomes in Shanghai, China: A prospective cohort study
por: Wu, Zheyuan, et al.
Publicado: (2023)

Minimal inhibitory concentrations of first-line drugs of multidrug-resistant tuberculosis isolates
por: Schönfeld, Nicolas, et al.
Publicado: (2012)

Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
por: Eker, Barbara, et al.
Publicado: (2008)

In vitro Synergism of Six Antituberculosis Agents Against Drug-Resistant Mycobacterium tuberculosis Isolated from Retreatment Tuberculosis Patients
por: Ying, Ruoyan, et al.
Publicado: (2021)

Impact of Molecular Drug Susceptibility Testing on the Time to Multidrug-resistant Tuberculosis Treatment Initiation
por: Jeon, Doosoo, et al.
Publicado: (2020)

Genetic Diversity and Drug Susceptibility Profiles of Multidrug-Resistant Tuberculosis Strains in Southeast China
por: Lin, Shufang, et al.
Publicado: (2021)

Five-antituberculosis Drug-resistance Genes Detection Using Array System
por: Shimizu, Yasuo, et al.
Publicado: (2008)

Antituberculosis Drug Resistance Survey in Lesotho, 2008-2009: Lessons Learned
por: Maama-Maime, Llang B., et al.
Publicado: (2015)

Combination Effect of Antituberculosis Drugs and Ethanolic Extract of Selected Medicinal Plants against Multi-Drug Resistant Mycobacterium tuberculosis Isolates
por: Fauziyah, Prabasiwi Nur, et al.
Publicado: (2017)

Prediction of drug resistance profile of multidrug-resistant Mycobacterium tuberculosis (MDR-MTB) isolates from newly diagnosed case by whole genome sequencing (WGS): a study from a high tuberculosis burden country
por: Sun, Wenwen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_us8c86fqfd8q506t3n8js38ubd